HighVista Strategies’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.43M | Sell |
45,620
-21,168
| -32% | -$663K | 0.52% | 73 |
|
|
2025
Q1 | $2.24M | Hold |
66,788
| – | – | 0.86% | 27 |
|
|
2024
Q4 | $2.62M | Sell |
66,788
-6,974
| -9% | -$273K | 0.97% | 25 |
|
|
2024
Q3 | $2.9M | Buy |
73,762
+1,047
| +1% | +$41.2K | 1% | 31 |
|
|
2024
Q2 | $2.84M | Hold |
72,715
| – | – | 1.04% | 22 |
|
|
2024
Q1 | $3.13M | Buy |
72,715
+20,914
| +40% | +$900K | 1.12% | 25 |
|
|
2023
Q4 | $2.39M | Buy |
51,801
+16,546
| +47% | +$762K | 0.87% | 37 |
|
|
2023
Q3 | $1.2M | Buy |
35,255
+17,680
| +101% | +$604K | 0.56% | 50 |
|
|
2023
Q2 | $677K | Sell |
17,575
-7,765
| -31% | -$299K | 0.31% | 101 |
|
|
2023
Q1 | $907K | Hold |
25,340
| – | – | 0.74% | 39 |
|
|
2022
Q4 | $999K | Buy |
25,340
+2,768
| +12% | +$109K | 0.59% | 45 |
|
|
2022
Q3 | $815K | Buy |
22,572
+137
| +0.6% | +$4.95K | 0.47% | 54 |
|
|
2022
Q2 | $682K | Sell |
22,435
-5,557
| -20% | -$169K | 0.41% | 57 |
|
|
2022
Q1 | $856K | Sell |
27,992
-34,914
| -56% | -$1.07M | 0.54% | 52 |
|
|
2021
Q4 | $1.97M | Sell |
62,906
-12,140
| -16% | -$379K | 1.56% | 13 |
|
|
2021
Q3 | $1.15M | Buy |
75,046
+34,087
| +83% | +$521K | 0.76% | 44 |
|
|
2021
Q2 | $763K | Buy |
+40,959
| New | +$763K | 0.54% | 60 |
|
|
2020
Q4 | – | Sell |
-43,517
| Closed | -$482K | – | 133 |
|
|
2020
Q3 | $482K | Buy |
43,517
+23,278
| +115% | +$258K | 0.35% | 54 |
|
|
2020
Q2 | $254K | Buy |
+20,239
| New | +$254K | 0.21% | 70 |
|